Niche Interactions Lock Down Leukemia Cells
Researchers unravel the mystery of epithelial to mesenchymal transition in acute lymphoblastic leukemia with co-culture techniques, CRISPR-screening, and RNA sequencing. (Source: The Scientist)
Source: The Scientist - September 24, 2023 Category: Science Tags: News News & Opinion Source Type: news
Leukemia With IKZF ₁ Deletion Benefits From Prolonged Maintenance Therapy
MONDAY, July 31, 2023 -- For children with acute lymphoblastic leukemia (ALL), cases with IKZF ₁ deletion (IKZF₁del) benefit from prolonged maintenance therapy, according to a study published online July 17 in the Journal of Clinical... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 31, 2023 Category: Pharmaceuticals Source Type: news
Overweight/Obese BMI Linked to Worse Survival in Young People With Leukemia
THURSDAY, July 13, 2023 -- For adolescents and young adults (AYAs) with acute lymphoblastic leukemia (ALL), overweight/obese body mass index (BMI) is associated with worse outcomes, according to a study published online July 11 in Blood... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 13, 2023 Category: Pharmaceuticals Source Type: news
In Defense of Parasocial Relationships
I’ve been juggling parasocial relationships for most of my life. As a newly online kid in the 1990s, I downloaded programs that helped me make fan art featuring my favorite bands: Dashboard Confessional, Something Corporate, and Blink-182. Now, a couple decades later, I refer to these artists by their first names (Chris, Andrew, Mark) to my friends and family and passionately defend them on internet forums. Thanks to TikTok and Instagram, I can tell you with authority what their kitchens look like, what their dogs are named, and what they put in their morning smoothies. Is it any wonder I feel like I know them?
[time...
Source: TIME: Health - July 13, 2023 Category: Consumer Health News Authors: Angela Haupt and Video by Andrew D. Johnson Tags: Uncategorized healthscienceclimate Mental Health Source Type: news
Obesity Associated With Worse Outcomes in Adolescent/Young Adults Treated for ALL
(MedPage Today) -- Adolescents and young adults (AYAs) with acute lymphoblastic leukemia (ALL) who are overweight or obese and are treated with asparaginase-containing pediatric regimens, are likelier to have poorer outcomes than those with normal... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - July 12, 2023 Category: Hematology Source Type: news
Obesity, Overweight Shrinks Survival Rates Against Childhood Leukemia
WEDNESDAY, July 12, 2023 -- A growing obesity epidemic may affect the outcome of treatment for those dealing with cancer, according to a new study of adults and teens being treated for acute lymphoblastic leukemia (ALL).
Researchers called for... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - July 12, 2023 Category: General Medicine Source Type: news
FDA Grants Full Approval for Blincyto (blinatumomab) to Treat Minimal Residual Disease-Positive B-Cell Precursor Acute Lymphoblastic Leukemia
Conversion From Accelerated to Full Approval
Reinforces Blincyto as Standard of Care for Patients With Minimal Residual Disease at Baseline After Remission
THOUSAND OAKS, Calif., June 21, 2023 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - June 21, 2023 Category: Drugs & Pharmacology Source Type: news
Base-Edited CAR-T Product 'Potent' in Relapsed Childhood T-Cell ALL
(MedPage Today) -- The use of base editing to generate universal off-the-shelf chimeric antigen receptor (CAR) T cells in patients with relapsed T-cell acute lymphoblastic leukemia (ALL) should be further investigated based on promising interim... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - June 15, 2023 Category: Hematology Source Type: news
Episode 3: CAR T-Cell Therapy for B-Cell Acute Lymphoblastic Leukemia Episode 3: CAR T-Cell Therapy for B-Cell Acute Lymphoblastic Leukemia
Join Drs Amelia Langston and Bijal Shah as they discuss CAR T-cell therapy for B-cell acute lymphoblastic leukemia, including clinical trials and real-world experience from their centers.Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 13, 2023 Category: Consumer Health News Tags: Hematology-Oncology InDiscussion Source Type: news
Cross-Border US –Mexican Collaboration Drives Up ALL Survival Cross-Border US –Mexican Collaboration Drives Up ALL Survival
A close collaboration between hospitals across the US –Mexican border improved survival for children with acute lymphoblastic leukemia (ALL), underlining the power of shared knowledge and skills, say researchers.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 26, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
Cross-Border Collaboration Improves Survival in Pediatric Leukemia Patients
(MedPage Today) -- CHICAGO -- A cancer treatment collaboration between hospitals on the California/Mexico border aimed at improving survival by sharing knowledge, expertise, and resources among children with acute lymphoblastic leukemia (ALL... (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - May 25, 2023 Category: American Health Source Type: news
' Terrific Progress': Adding Blinatumomab for Infant Leukemia'Terrific Progress': Adding Blinatumomab for Infant Leukemia
The immunotherapy plus standard chemotherapy improved short-term outcomes for infants with acute lymphoblastic leukemia.MDedge News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 5, 2023 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
Blinatumomab Safe, Efficacious for Infants With KMT2A-Rearranged Leukemia
THURSDAY, April 27, 2023 -- For infants younger than 1 year of age with newly diagnosed KMT2A-rearranged acute lymphoblastic leukemia (ALL), a bispecific T-cell engager molecule targeting CD19, blinatumomab, is safe and has a high level of efficacy,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 27, 2023 Category: Pharmaceuticals Source Type: news
Blinatumomab Plus Chemo Effective in Aggressive Infant ALL
(MedPage Today) -- Adding a postinduction course of blinatumomab (Blincyto) to chemotherapy appeared safe and highly effective for treating an aggressive form of acute lymphoblastic leukemia (ALL) in infants, according to results from a phase II... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - April 26, 2023 Category: Hematology Source Type: news
Risk of Relapse Increased With Extreme Poverty in Children With Leukemia
MONDAY, April 24, 2023 -- For children receiving maintenance treatment for acute lymphoblastic leukemia (ALL), those living in extreme poverty have increased risk of relapse, according to a study published online April 17 in Blood.
Aman Wadhwa,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 24, 2023 Category: Pharmaceuticals Source Type: news
